Soci 2010 Soci 2011
« Indietro
20.09.2011

Helsinn Therapeutics Initiates Global Pivotal Phase III Clinical Program to Evaluate Anamorelin in Non-Small Cell Lung Cancer-Associated Anorexia/Cachexia


Comunicato Stampa Helsinn.pdf
 
 
Su

Username o email:

Password:

cancella testo (antispam)


Ricordami

Password dimenticata?